Skip to main content
Log in

Putting the Choice in Choice Tasks: Incorporating Preference Elicitation Tasks in Health Preference Research

  • Practical Application
  • Published:
The Patient - Patient-Centered Outcomes Research Aims and scope Submit manuscript

Abstract

Choice-based preference elicitation methods such as the discrete choice experiment (DCE) present hypothetical choices to respondents, with an expectation that these hypothetical choices accurately reflect a ‘real world’ health-related decision context and that consequently the choice data can be held to be a true representation of the respondent’s health or treatment preferences. For this to be the case, careful consideration needs to be given to the format of the choice task in a choice experiment. The overarching aim of this paper is to highlight important aspects to consider when designing and ‘setting up’ the choice tasks to be presented to respondents in a DCE. This includes the importance of considering the potential impact of format (e.g. choice context, choice set presentation and size) as well as choice set content (e.g. labelled and unlabelled choice sets and inclusion of reference alternatives) and choice questions (stated choice versus additional questions designed to explore complete preference orders) on the preference estimates that are elicited from studies. We endeavoure to instil a holistic approach to choice task design that considers format alongside content, experimental design and analysis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Data availability

Not applicable.

References

  1. Whitty JA, de Bekker-Grob EW, Cook NS, et al. Patient preferences in the medical product lifecycle. Patient. 2020;13(1):7–10. https://doi.org/10.1007/s40271-019-00400-y.

    Article  PubMed  Google Scholar 

  2. The PREFER Consortium. PREFER Recommendations - Why, when and how to assess and use patient preferences in medical product decision-making. 2022. Available at: https://zenodo.org/records/6592304. Accessed 19 Jan 2024.

  3. Bouvy JC, Cowie L, Lovett R, Morrison D, Livingstone H, Crabb N. Use of patient preference studies in HTA decision making: a NICE Perspective. Patient. 2020;13(2):145–9. https://doi.org/10.1007/s40271-019-00408-4.

    Article  PubMed  Google Scholar 

  4. US FDA. Benefit-Risk Assessment for New Drug and Biological Products. Guidance for Industry. Silver Spring, MD: US FDA; 2023.

  5. Janssens R, Barbier L, Muller M, et al. How can patient preferences be used and communicated in the regulatory evaluation of medicinal products? Findings and recommendations from IMI PREFER and call to action. Front Pharmacol. 2023;14:1192770. https://doi.org/10.3389/fphar.2023.1192770.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Wang H, Rowen DL, Brazier JE, Jiang L. Discrete Choice experiments in health state valuation: a systematic review of progress and new trends. Appl Health Econ Health Policy. 2023;21(3):405–18. https://doi.org/10.1007/s40258-023-00794-9.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Soekhai V, Whichello C, Levitan B, et al. Methods for exploring and eliciting patient preferences in the medical product lifecycle: a literature review. Drug Discov Today. 2019;24(7):1324–31. https://doi.org/10.1016/j.drudis.2019.05.001.

    Article  PubMed  Google Scholar 

  8. Whichello C, Levitan B, Juhaeri J, et al. Appraising patient preference methods for decision-making in the medical product lifecycle: an empirical comparison. BMC Med Inform Decis Mak. 2020;20(1):114. https://doi.org/10.1186/s12911-020-01142-w.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Lancsar E, Swait J. Reconceptualising the external validity of discrete choice experiments. Pharmacoeconomics. 2014;32(10):951–65. https://doi.org/10.1007/s40273-014-0181-7.

    Article  PubMed  Google Scholar 

  10. Haghani M, Bliemer MCJ, Rose JM, Oppewal H, Lancsar E. Hypothetical bias in stated choice experiments: part II. Conceptualisation of external validity, sources and explanations of bias and effectiveness of mitigation methods. J Choice Modell. 2021;41:100322. https://doi.org/10.1016/j.jocm.2021.100322.

    Article  Google Scholar 

  11. Haghani M, Bliemer MCJ, Rose JM, Oppewal H, Lancsar E. Hypothetical bias in stated choice experiments: part I. Macro-scale analysis of literature and integrative synthesis of empirical evidence from applied economics, experimental psychology and neuroimaging. J Choice Model. 2021;41:100309. https://doi.org/10.1016/j.jocm.2021.100309.

    Article  Google Scholar 

  12. Bridges JF, Hauber AB, Marshall D, et al. Conjoint analysis applications in health–a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health. 2011;14(4):403–13. https://doi.org/10.1016/j.jval.2010.11.013.

    Article  PubMed  Google Scholar 

  13. Lancsar E, Louviere J. Conducting discrete choice experiments to inform healthcare decision making: a user’s guide. Pharmacoeconomics. 2008;26(8):661–77. https://doi.org/10.2165/00019053-200826080-00004.

    Article  PubMed  Google Scholar 

  14. Ramos-Goni JM, Oppe M, Slaap B, Busschbach JJ, Stolk E. Quality control process for EQ-5D-5L valuation studies. Value Health. 2017;20(3):466–73. https://doi.org/10.1016/j.jval.2016.10.012.

    Article  PubMed  Google Scholar 

  15. Spinks J, Mortimer D. Lost in the crowd? Using eye-tracking to investigate the effect of complexity on attribute non-attendance in discrete choice experiments. BMC Med Inform Decis Mak. 2016;16:14. https://doi.org/10.1186/s12911-016-0251-1.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Karimi M, Brazier J, Paisley S. How do individuals value health states? A qualitative investigation. Soc Sci Med. 2017;172:80–8. https://doi.org/10.1016/j.socscimed.2016.11.027.

    Article  CAS  PubMed  Google Scholar 

  17. Campoamor NB, Guerrini CJ, Brooks WB, Bridges JFP, Crossnohere NL. Pretesting discrete-choice experiments: a guide for researchers. Patient. 2024;17(2):109–20. https://doi.org/10.1007/s40271-024-00672-z.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Bansal P, Kim E-J, Ozdemir S. Discrete choice experiments with eye-tracking: how far we have come and a way forward. J Choice Model. 2024;51: 100478. https://doi.org/10.1016/j.jocm.2024.100478.

    Article  Google Scholar 

  19. Soekhai V, de Bekker-Grob EW, Ellis AR, Vass CM. Discrete choice experiments in health economics: past, present and future. Pharmacoeconomics. 2019;37(2):201–26. https://doi.org/10.1007/s40273-018-0734-2.

    Article  PubMed  Google Scholar 

  20. Jonker MF, Donkers B, de Bekker-Grob E, Stolk EA. Attribute level overlap (and color coding) can reduce task complexity, improve choice consistency, and decrease the dropout rate in discrete choice experiments. Health Econ. 2019;28(3):350–63. https://doi.org/10.1002/hec.3846.

    Article  PubMed  Google Scholar 

  21. Regier DA, Watson V, Burnett H, Ungar WJ. Task complexity and response certainty in discrete choice experiments: An application to drug treatments for juvenile idiopathic arthritis. J Behav Exp Econ. 2014;50:40–9. https://doi.org/10.1016/j.socec.2014.02.009.

    Article  Google Scholar 

  22. Swait J, Adamowicz W. Choice environment, market complexity, and consumer behavior: a theoretical and empirical approach for incorporating decision complexity into models of consumer choice. Organ Behav Hum Decis Process. 2001;86(2):141–67. https://doi.org/10.1006/obhd.2000.2941.

    Article  Google Scholar 

  23. Kragt M, Bennett J. Designing choice experiments to test for anchoring and framing effects. Canberra: Australian National University; 2008.

    Google Scholar 

  24. Tversky A, Kahneman D. The framing of decisions and the psychology of choice. Science. 1981;211(4481):453–8. https://doi.org/10.1126/science.7455683.

    Article  CAS  PubMed  Google Scholar 

  25. Kahneman D, Tversky A. Choices, values, and frames. Am Psychol. 1984;39(4):341–50. https://doi.org/10.1037/0003-066X.39.4.341.

    Article  Google Scholar 

  26. Levin IP, Schneider SL, Gaeth GJ. All frames are not created equal: a typology and critical analysis of framing effects. Organ Behav Hum Decis Process. 1998;76(2):149–88. https://doi.org/10.1006/obhd.1998.2804.

    Article  CAS  PubMed  Google Scholar 

  27. Hallahan K. Seven models of framing: implications for public relations. J Public Relations Res. 1999;11(3):205–42. https://doi.org/10.1207/s1532754xjprr1103_02.

    Article  Google Scholar 

  28. O’Connor AM, Boyd NF, Tritchler DL, Kriukov Y, Sutherland H, Till JE. Eliciting preferences for alternative cancer drug treatments. The influence of framing, medium, and rater variables. Med Decis Making. 1985;5(4):453–63. https://doi.org/10.1177/0272989X8500500408.

    Article  CAS  PubMed  Google Scholar 

  29. Howard K, Salkeld G. Does attribute framing in discrete choice experiments influence willingness to pay? Results from a discrete choice experiment in screening for colorectal cancer. Value Health. 2009;12(2):354–63. https://doi.org/10.1111/j.1524-4733.2008.00417.x.

    Article  PubMed  Google Scholar 

  30. Kragt ME, Bennett JW. Attribute framing in choice experiments: how do attribute level descriptions affect value estimates? Environ Resource Econ. 2012;51(1):43–59. https://doi.org/10.1007/s10640-011-9487-5.

    Article  Google Scholar 

  31. Smith IP, Ancillotti M, de Bekker-Grob EW, Veldwijk J. Does It matter how you ask? Assessing the impact of failure or effectiveness framing on preferences for antibiotic treatments in a discrete choice experiment. Patient Prefer Adherence. 2022;16:2921–36. https://doi.org/10.2147/PPA.S365624.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Veldwijk J, Essers BA, Lambooij MS, Dirksen CD, Smit HA, de Wit GA. Survival or mortality: does risk attribute framing influence decision-making behavior in a discrete choice experiment? Value Health. 2016;19(2):202–9. https://doi.org/10.1016/j.jval.2015.11.004.

    Article  PubMed  Google Scholar 

  33. Kenny P, Goodall S, Street DJ, Greene J. Choosing a doctor: does presentation format affect the way consumers use health care performance information? Patient. 2017;10(6):739–51. https://doi.org/10.1007/s40271-017-0245-9.

    Article  PubMed  Google Scholar 

  34. Benning TM, Dellaert BG, Severens JL, Dirksen CD. The effect of presenting information about invasive follow-up testing on individuals’ noninvasive colorectal cancer screening participation decision: results from a discrete choice experiment. Value Health. 2014;17(5):578–87. https://doi.org/10.1016/j.jval.2014.04.007.

    Article  PubMed  Google Scholar 

  35. Knox SA, Viney RC, Gu Y, et al. The effect of adverse information and positive promotion on women’s preferences for prescribed contraceptive products. Soc Sci Med. 2013;83:70–80. https://doi.org/10.1016/j.socscimed.2012.12.025.

    Article  PubMed  Google Scholar 

  36. Ghijben P, Lancsar E, Zavarsek S. Preferences for oral anticoagulants in atrial fibrillation: a best-best discrete choice experiment. Pharmacoeconomics. 2014;32(11):1115–27. https://doi.org/10.1007/s40273-014-0188-0.

    Article  PubMed  Google Scholar 

  37. Blake MR, Lancsar E, Peeters A, Backholer K. Sugar-sweetened beverage price elasticities in a hypothetical convenience store. Soc Sci Med. 2019;225:98–107. https://doi.org/10.1016/j.socscimed.2019.02.021.

    Article  PubMed  Google Scholar 

  38. Campbell D, Erdem S. Including opt-out options in discrete choice experiments: issues to consider. Patient. 2019;12(1):1–14. https://doi.org/10.1007/s40271-018-0324-6.

    Article  PubMed  Google Scholar 

  39. Hensher DA, Rose JM, Greene WH. Applied choice analysis: a primer. Cambridge: Cambridge University Press; 2005.

    Book  Google Scholar 

  40. Viney R, Lancsar E, Louviere J. Discrete choice experiments to measure consumer preferences for health and healthcare. Expert Rev Pharmacoecon Outcomes Res. 2002;2(4):319–26. https://doi.org/10.1586/14737167.2.4.319.

    Article  PubMed  Google Scholar 

  41. Ryan M, Skatun D. Modelling non-demanders in choice experiments. Health Econ. 2004;13(4):397–402. https://doi.org/10.1002/hec.821.

    Article  PubMed  Google Scholar 

  42. Veldwijk J, Lambooij MS, de Bekker-Grob EW, Smit HA, de Wit GA. The effect of including an opt-out option in discrete choice experiments. PLoS ONE. 2014;9(11): e111805. https://doi.org/10.1371/journal.pone.0111805.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Norman R, Mulhern B, Lancsar E, et al. The use of a discrete choice experiment including both duration and dead for the development of an EQ-5D-5L value set for Australia. Pharmacoeconomics. 2023;41(4):427–38. https://doi.org/10.1007/s40273-023-01243-0.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Jonker MF, Donkers B, de Bekker-Grob EW, Stolk EA. Advocating a paradigm shift in health-state valuations: the estimation of time-preference corrected QALY tariffs. Value Health. 2018;21(8):993–1001. https://doi.org/10.1016/j.jval.2018.01.016.

    Article  PubMed  Google Scholar 

  45. Mulhern B, Norman R, Street DJ, Viney R. One method, many methodological choices: a structured review of discrete-choice experiments for health state valuation. Pharmacoeconomics. 2019;37(1):29–43. https://doi.org/10.1007/s40273-018-0714-6.

    Article  PubMed  Google Scholar 

  46. Salkeld G, Ryan M, Short L. The veil of experience: do consumers prefer what they know best? Health Econ. 2000;9(3):267–70. https://doi.org/10.1002/(sici)1099-1050(200004)9:3%3c267::aid-hec511%3e3.0.co;2-h.

    Article  CAS  PubMed  Google Scholar 

  47. Brazell JD, Diener CG, Karniouchina E, Moore WL, Severin V, Uldry P-F. The no-choice option and dual response choice designs. Market Lett. 2006;17:255–68.

    Article  Google Scholar 

  48. Laba TL, Howard K, Rose J, et al. Patient preferences for a polypill for the prevention of cardiovascular diseases. Ann Pharmacother. 2015;49(5):528–39. https://doi.org/10.1177/1060028015570468.

    Article  PubMed  Google Scholar 

  49. Marshall DA, Johnson FR, Kulin NA, et al. How do physician assessments of patient preferences for colorectal cancer screening tests differ from actual preferences? A comparison in Canada and the United States using a stated-choice survey. Health Econ. 2009;18(12):1420–39. https://doi.org/10.1002/hec.1437.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Marshall DA, Johnson FR, Phillips KA, Marshall JK, Thabane L, Kulin NA. Measuring patient preferences for colorectal cancer screening using a choice-format survey. Value Health. 2007;10(5):415–30. https://doi.org/10.1111/j.1524-4733.2007.00196.x.

    Article  PubMed  Google Scholar 

  51. Lancsar EJ, Hall JP, King M, et al. Using discrete choice experiments to investigate subject preferences for preventive asthma medication. Respirology. 2007;12(1):127–36. https://doi.org/10.1111/j.1440-1843.2006.01005.x.

    Article  PubMed  Google Scholar 

  52. Louviere JJ, Islam T, Wasi N, Street D, Burgess L. Designing discrete choice experiments: do optimal designs come at a price? J Consum Res. 2008;35(2):360–75. https://doi.org/10.1086/586913.

    Article  Google Scholar 

  53. Louviere JJ, Hensher DA, Swait JD. Stated choice methods: analysis and applications. Cambridge: Cambridge University Press; 2010.

    Google Scholar 

  54. de Bekker-Grob EW, Hol L, Donkers B, et al. Labeled versus unlabeled discrete choice experiments in health economics: an application to colorectal cancer screening. Value Health. 2010;13(2):315–23. https://doi.org/10.1111/j.1524-4733.2009.00670.x.

    Article  PubMed  Google Scholar 

  55. Jin W, Jiang H, Liu Y, Klampfl E. Do labeled versus unlabeled treatments of alternatives’ names influence stated choice outputs? Results from a mode choice study. PLoS ONE. 2017;12(8): e0178826. https://doi.org/10.1371/journal.pone.0178826.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. McFadden D. Conditional logit analysis of qualitative choice behavior. In: Zarembka P, editor. Frontiers in econometrics. Academic Press; 1973. p. 105–42.

    Google Scholar 

  57. Beggs S, Cardell S, Hausman J. Assessing the potential demand for electric cars. J Economet. 1981;17(1):1–19. https://doi.org/10.1016/0304-4076(81)90056-7.

    Article  Google Scholar 

  58. Chapman RG, Staelin R. Exploiting rank ordered choice set data within the stochastic utility model. J Market Res. 1982;19(3):288–301. https://doi.org/10.2307/3151563.

    Article  Google Scholar 

  59. de Bekker-Grob EW, Ryan M, Gerard K. Discrete choice experiments in health economics: a review of the literature. Health Econ. 2012;21(2):145–72. https://doi.org/10.1002/hec.1697.

    Article  PubMed  Google Scholar 

  60. Lancsar E, Fiebig DG, Hole AR. Discrete choice experiments: a guide to model specification, estimation and software. Pharmacoeconomics. 2017;35(7):697–716. https://doi.org/10.1007/s40273-017-0506-4.

    Article  PubMed  Google Scholar 

  61. Lancsar E, Louviere J, Donaldson C, Currie G, Burgess L. Best worst discrete choice experiments in health: methods and an application. Soc Sci Med. 2013;76(1):74–82. https://doi.org/10.1016/j.socscimed.2012.10.007.

    Article  PubMed  Google Scholar 

  62. Flynn TN, Louviere JJ, Peters TJ, Coast J. Best–worst scaling: What it can do for health care research and how to do it. J Health Econ. 2007;26(1):171–89. https://doi.org/10.1016/j.jhealeco.2006.04.002.

    Article  PubMed  Google Scholar 

  63. Whitty JA, Oliveira Goncalves AS. A systematic review comparing the acceptability, validity and concordance of discrete choice experiments and best-worst scaling for eliciting preferences in healthcare. Patient. 2018;11(3):301–17. https://doi.org/10.1007/s40271-017-0288-y.

    Article  PubMed  Google Scholar 

  64. Whitty JA, Walker R, Golenko X, Ratcliffe J. A think aloud study comparing the validity and acceptability of discrete choice and best worst scaling methods. PLoS ONE. 2014;9(4): e90635. https://doi.org/10.1371/journal.pone.0090635.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Huls SPI, Lancsar E, Donkers B, Ride J. Two for the price of one: If moving beyond traditional single-best discrete choice experiments, should we use best-worst, best-best or ranking for preference elicitation? Health Econ. 2022;31(12):2630–47. https://doi.org/10.1002/hec.4599.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements/Funding

This research received no specific funding. Jennifer Whitty is an employee of Evidera, a clinical research organisation that receives funding from research contracts for undertaking patient preference research. Editorial services were provided by Fritz Hamme and Michael Grossi of Evidera.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jennifer A. Whitty.

Ethics declarations

Author Contributions

All authors conceived of the concept for this manuscript, developed the draft of this manuscript, reviewed the manuscript for key academic content, and approved the final version for submission.

Competing Interests

None declared.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Whitty, J.A., Lancsar, E., De Abreu Lourenco, R. et al. Putting the Choice in Choice Tasks: Incorporating Preference Elicitation Tasks in Health Preference Research. Patient (2024). https://doi.org/10.1007/s40271-024-00696-5

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s40271-024-00696-5

Navigation